Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Attilio Olivieri
Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients With Multiple Myeloma or Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients With AML Evaluated Using a Simplified Multidimensional Geriatric Assessment
Advances in Therapy
Medicine
Pharmacology
Related publications
Intermediate-Dose Ara-C Plus G-CSF for Stem Cell Mobilization in Patients With Lymphoid Malignancies, Including Predicted Poor Mobilizers
Bone Marrow Transplantation
Transplantation
Hematology
Comparison of Peripheral Blood Progenitor Cell Mobilization in Patients With Multiple Myeloma: High-Dose Cyclophosphamide Plus GM-CSF vs G-CSF Alone
Bone Marrow Transplantation
Transplantation
Hematology
Development and Implementation of Plerixafor Plus G-CSF Mobilization Algorithm for Autologous Stem Cell Transplant (ASCT) in Multiple Myeloma (MM) Patients Treated at Memorial Sloan-Kettering Cancer Center (MSKCC)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Increased Efficacy of Stem Cell Chemo-Mobilization With Intermediate-Dose Cytarabine Plus G-CSF Compared With G-CSF Alone in Patients With Multiple Myeloma: Results of a Randomized Trial,
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts From Healthy Stem Cell Donors Mobilized With Either G-CSF Alone or G-CSF and Plerixafor
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Infectious Complications After High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Comparison Between Patients With Lymphoma or Multiple Myeloma and Patients With Solid Tumors
Bone Marrow Transplantation
Transplantation
Hematology
Impact of Plerixafor Use at Different Peripheral Blood CD34+ Cell Thresholds on Autologous Stem Cell Collection in Patients With Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
rhTPO Combined With Chemotherapy and G-CSF for Autologous Peripheral Blood Stem Cells in Patients With Refractory/Relapsed Non-Hodgkin’s Lymphoma
Cancer Management and Research
Oncology
